2024
Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis
Wang Y, Wang H, Ma X, Zhu Z, Tian X, Fu R, Jia L. Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis. BMC Nephrology 2024, 25: 35. PMID: 38273279, PMCID: PMC10811929, DOI: 10.1186/s12882-024-03465-6.Peer-Reviewed Original ResearchConceptsIgAN patientsFibrinogen degradation productsIgA nephropathyIgAVN patientsLevels of plasma D-dimerLevels of serum creatininePartial remission rateSevere coagulation abnormalitiesPlasma D-dimerPoor renal functionChronic kidney injuryRemission ratePathological resultsSerum creatinineAbdominal symptomsRenal functionCoagulation abnormalitiesDeposition of fibrinogenKidney biopsyD-dimerKidney injuryCoagulation functionIgAVNIgAN groupMethodsA total
2023
Carbon dioxide angiography during peripheral vascular interventions is associated with decreased cardiac and renal complications in patients with chronic kidney disease
Lee S, Ali S, Cardella J, Turner J, Guzman R, Dardik A, Ochoa Chaar C. Carbon dioxide angiography during peripheral vascular interventions is associated with decreased cardiac and renal complications in patients with chronic kidney disease. Journal Of Vascular Surgery 2023, 78: 201-208. PMID: 36948278, DOI: 10.1016/j.jvs.2023.03.029.Peer-Reviewed Original ResearchConceptsAdvanced chronic kidney diseaseChronic kidney diseasePeripheral vascular interventionsContrast volume usagePC-AKICarbon dioxide angiographyCardiac complicationsPropensity matchingKidney diseaseVascular interventionsPost-contrast acute kidney injuryAcute kidney injuryOutcomes of patientsPeripheral arterial diseasePoor renal functionMultivariate logistic regressionLower contrast volumeVolume of contrastCardiac comorbiditiesKidney injuryMinor amputationRenal complicationsRenal functionEndovascular therapyArterial disease
2022
Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
Mullens W, Martens P, Testani JM, Tang WHW, Skouri H, Verbrugge FH, Fudim M, Iacoviello M, Franke J, Flammer AJ, Palazzuoli A, Barragan PM, Thum T, Marcos MC, Miró Ò, Rossignol P, Metra M, Lassus J, Orso F, Jankowska EA, Chioncel O, Milicic D, Hill L, Seferovic P, Rosano G, Coats A, Damman K. Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology. European Journal Of Heart Failure 2022, 24: 603-619. PMID: 35239201, DOI: 10.1002/ejhf.2471.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsChronic heart failureHeart failureRenal functionEjection fractionClinical practiceConsensus documentSodium-glucose cotransporter 2 inhibitorsGuideline-directed medical therapyReduced ejection fraction patientsEjection fraction patientsHeart Failure AssociationCotransporter 2 inhibitorsEuropean SocietyPharmacologic treatment optionsPoor renal functionDisease-modifying therapiesGood clinical practiceTreatment-induced changesDrug implementationHF drugsCardiology guidelinesESC guidelinesRenal effectsMedical therapyLifesaving therapy
2008
Renal pyramid echogenicity in ureteropelvic junction obstruction: correlation between altered echogenicity and differential renal function
Chavhan G, Daneman A, Moineddin R, Lim R, Langlois V, Traubici J. Renal pyramid echogenicity in ureteropelvic junction obstruction: correlation between altered echogenicity and differential renal function. Pediatric Radiology 2008, 38: 1068. PMID: 18633607, DOI: 10.1007/s00247-008-0943-5.Peer-Reviewed Original ResearchConceptsDifferential renal functionLoss of corticomedullary differentiationUreteropelvic junction obstructionPoor renal functionCorticomedullary differentiationUreteropelvic junctionRenal functionGroup 1Risk ratioObstructed kidneyGroup 2Increased echogenicityGroup 3Technetium-99m mercaptoacetyltriglycineResultsIn group 1Fisher's exact testAbnormal echogenicityObstructive hydronephrosisExact testTechnetium-99Histological changesRenal pyramidsHigh-frequency transducersEchogenicityPatients
2005
The significance of elevated troponin T in patients with nondialysis‐dependent renal insufficiency: A validation with coronary angiography
Heitner JF, Curtis JP, Haq SA, Corey GR, Newby LK, Jollis JG. The significance of elevated troponin T in patients with nondialysis‐dependent renal insufficiency: A validation with coronary angiography. Clinical Cardiology 2005, 28: 333-336. PMID: 16075826, PMCID: PMC6653870, DOI: 10.1002/clc.4960280706.Peer-Reviewed Original ResearchConceptsPoor renal functionCoronary artery diseaseLength of stayNondialysis-dependent renal insufficiencyElevated troponin TNormal renal functionRenal functionElevated cTnTCoronary angiographyCAD stenosisContrast nephropathyPositive cTnTRenal insufficiencyPrevalence of CADTroponin TSignificant coronary artery diseaseSignificant coronary artery stenosisImpaired renal functionAcute coronary syndromeFuture cardiac eventsInitiation of hemodialysisGlomerular filtration rateCoronary artery stenosisElevated cTnT.Hospital mortality
2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Kaufman D, Carducci M, Kuzel T, Todd M, Oh W, Smith M, Ye Z, Nicol S, Stadler W. A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. Urologic Oncology Seminars And Original Investigations 2004, 22: 393-397. PMID: 15464919, DOI: 10.1016/j.urolonc.2004.01.002.Peer-Reviewed Original ResearchConceptsMetastatic urothelial cancerUrothelial cancerResponse rateMulti-institutional phase II trialPhase II trial of gemcitabineTrial of gemcitabineAdequate organ functionWorld Health OrganizationPoor renal functionOverall response ratePartial responseCombined gemcitabineMedian survivalPrognostic groupsInsufficiency patientsPerformance statusRenal functionTherapy statusGrade 3Treated patientsBiweekly schedulePatientsRoutine useOrgan functionGemcitabine
2002
Spectrum of heart failure in older patients: Results from the national heart failure project
Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: Results from the national heart failure project. American Heart Journal 2002, 143: 412-417. PMID: 11868045, DOI: 10.1067/mhj.2002.120773.Peer-Reviewed Original ResearchConceptsLong-term care facilitiesHeart failureCare facilitiesElderly patientsClinical trialsNational Heart Failure ProjectLeft ventricular ejection fractionLeft ventricular systolic functionChronic obstructive pulmonary diseaseAssociated laboratory abnormalitiesHeart Failure ProjectHistory of hypertensionPoor renal functionThird of patientsVentricular systolic functionMajority of patientsMultiple comorbid conditionsObstructive pulmonary diseaseVentricular ejection fractionExclusion of patientsLong-term hemodialysisCoronary heart diseasePopulation-based studyAcute care facilitiesEvidence-based guidance
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply